Dr. Anuj Goel

Chief Development Officer

Dr Anuj Goel is the Chief Development Officer (CDO) at Biocon Biologics since October 2024, leading all Research & Development functions; R&D-CMC, Clinical Development & Medical Affairs (CDMA) and Regulatory Affairs.

Anuj is a Biocon veteran, having joined the Company in 1996 to start the process development group in R&D. He has had diverse experience working on solid state fermentation, deep tank enzyme production, fermentation of small molecules metabolites and recombinant proteins and peptides using bacterial, fungal and mammalian cell lines.

Over the years, his team has developed technology for statins, immunosuppressants, recombinant proteins, insulins and monoclonal antibodies. Anuj has been instrumental in transforming our development labs into premier facilities that drive R&D excellence, fostering innovation and growth.

Anuj brings extensive experience and comprehensive organizational leadership, having served as a bench scientist, project manager, portfolio leader, function head and most recently, leading R&D-CMC department. He has mentored many emerging leaders at Biocon Biologics, demonstrating his exceptional leadership skills.

Anuj has also been a key stakeholder in advancing the biosimilars portfolio over the years through collaborations with partners and stakeholders.

He has a deep understanding of the overall business and has significantly contributed to shaping our strategy, offering valuable insights on various organizational matters.

Anuj holds a PhD in Biotechnology from the University of Pune and has over 15 publications and patents to his credit.